Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for synthesizing Ranolazine

A synthesis method and technology of ranolazine are applied in a new synthesis field and can solve the problems of difficulty in synthesis of ranolazine, long reaction steps, and low yield of the synthesis method.

Inactive Publication Date: 2007-02-21
TIANJIN HANKANG PHARMA BIOTECH
View PDF4 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The first synthetic route has short reaction steps and easy-to-obtain raw materials. Although piperazine is used in a large amount, it is cheap and easy to obtain; the difference between the second route and the first route is that after the reaction between o-methoxyphenol and epichlorohydrin Condensate with piperazine and then react with N-(2,6-dimethylphenyl)-2-chloroacetamide to prepare ranolazine; the third synthetic route has long reaction steps
[0010] The yields of the above synthetic methods are not high. Although the first synthetic route has great application value, there are still many steps and conditions that need to be improved to increase the yield. The present invention is based on this, and after screening and research, it has found Better process conditions solve the difficult problem of ranolazine synthesis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for synthesizing Ranolazine
  • Method for synthesizing Ranolazine
  • Method for synthesizing Ranolazine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] 1. Preparation of 3-(2-methoxyphenoxy)-1,2-propylene oxide (intermediate I) (yield: 80%)

[0032] Feed ratio: o-methoxyphenol: epichlorohydrin dioxane: water: NaOH = 1: 1.68: 2.7: 1.2: 0.36 (w / v / v / w)

[0033] Add 150g of o-methoxyphenol, 378ml of dioxane, 168ml of water and 50g of NaOH into a 2L three-necked reaction flask, add 252ml of epichlorohydrin under stirring at room temperature, and react under reflux for 2 hours. Cool to room temperature, add ethyl acetate, filter, separate the organic layer, extract the aqueous layer twice with ethyl acetate, combine the organic layers, dry with anhydrous sodium sulfate, distill under reduced pressure, collect 121-124 ° C / 2KPa fractions to obtain 163g product.

[0034] 2. Preparation of 2-chloro-N-(2,6xylyl)acetamide (yield: 84.3%)

[0035] Feed ratio: 2,6-dimethylaniline: chloroacetyl chloride: triethylamine: toluene = 1: 0.94: 1.0: 10 (w / w / w / v)

[0036] Add 165g of 2,6-dimethylaniline, 165g of triethylamine, and 1650ml...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention relates to a method for synthesizing ranolazine drug for treating stenocardia. The method comprises: performing amidation and N-monoalkylation on 2, 6-dimethylaniline to obtain N-(2, 6-xylyl)-2-(1-piperazine) acetamide, and then reacting with 2-(2-methoxyphenoxy) epoxyethane generated from o-methoxyphenol and epoxy chloropropane to obtain anolazine. The reactions include the refinery of 2-chloro-N-(2,6-xylyl)acetamide by cyclohexane and the recrystallization of ranolazine by ethanol / ethyl acetate (2:1), thus can raise the yield.

Description

Technical field: [0001] The invention relates to a new synthesis method of ranolazine, an antiangina drug. Background technique: [0002] Ranolazine (ranolazine) is a new type of metabolic regulator and cardioselective anti-anginal drug developed by Syntex Corporation of the United States. Its chemical name is (±)N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)-propyl]-1-piperazine amides. It can be used to treat myocardial infarction, congestive heart disease, angina pectoris, arrhythmia and other diseases. Its mechanism of action is to inhibit the oxidation of some fatty acids and change the oxidative metabolism of fatty acids in the heart to glucose oxidative metabolism, thereby reducing the oxygen consumption of the heart and not causing heart rate. and changes in blood pressure. Patent documents US4567264, EP0483932, and the Chinese journal "West China Pharmaceutical Journal" 2004, 19(3): 191-192 report several synthetic methods of ranolazine: [0003] 1) N-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D295/15
Inventor 严洁
Owner TIANJIN HANKANG PHARMA BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com